Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: Subdividing Ovarian and Peritoneal Serous Carcinoma Into Moderately Differentiated and Poorly Differentiated Does not Have Biologic Validity Based on Molecular Genetic and In Vitro Drug Resistance Data, The American Journal of Surgical Pathology, November 2008, Wolters Kluwer Health,
DOI: 10.1097/pas.0b013e31816fd555.
You can read the full text:
Contributors
The following have contributed to this page
